Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100053447Phase 4Recruiting
Phase 4 trial of ropivacaine and sufentanil in postoperative pain (2 arms), sponsored by North Sichuan Medical College. Primary endpoint: Pain VAS score. Started Nov 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100053447.